Cargando…

On the use of DNA as a linker in antibody-drug conjugates: synthesis, stability and in vitro potency

Here we present the synthesis and evaluation of antibody-drug conjugates (ADCs), for which antibody and drug are non-covalently connected using complementary DNA linkers. These ADCs are composed of trastuzumab, an antibody targeting HER2 receptors overexpressed on breast cancer cells, and monomethyl...

Descripción completa

Detalles Bibliográficos
Autores principales:	Dovgan, Igor, Ehkirch, Anthony, Lehot, Victor, Kuhn, Isabelle, Koniev, Oleksandr, Kolodych, Sergii, Hentz, Alexandre, Ripoll, Manon, Ursuegui, Sylvain, Nothisen, Marc, Cianférani, Sarah, Wagner, Alain
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7203131/ https://www.ncbi.nlm.nih.gov/pubmed/32376903 http://dx.doi.org/10.1038/s41598-020-64518-y

Ejemplares similares

Automated linkage of proteins and payloads producing monodisperse conjugates
por: Dovgan, Igor, et al.
Publicado: (2020)

2-(Maleimidomethyl)-1,3-Dioxanes (MD): a Serum-Stable Self-hydrolysable Hydrophilic Alternative to Classical Maleimide Conjugation
por: Dovgan, Igor, et al.
Publicado: (2016)

Non-specific interactions of antibody-oligonucleotide conjugates with living cells
por: Lehot, Victor, et al.
Publicado: (2021)

Reinvestigation of the Automated Synthesis of Stoichiometrically Conjugated Antibodies to Access High Molecular Weight Payloads and Multiplexed Conjugation via an In-Solution Trans-Tagging Process
por: Lehot, Victor, et al.
Publicado: (2023)

Targeted Anticancer Agent with Original Mode of Action Prepared by Supramolecular Assembly of Antibody Oligonucleotide Conjugates and Cationic Nanoparticles
por: Lehot, Victor, et al.
Publicado: (2023)

Bicyclo[6.1.0]nonyne carboxylic acid for the production of stable molecular probes
por: Rady, Tony, et al.
Publicado: (2021)

Targeting the tumour microenvironment with an enzyme-responsive drug delivery system for the efficient therapy of breast and pancreatic cancers
por: Renoux, Brigitte, et al.
Publicado: (2017)

An in vivo strategy to counteract post-administration anticoagulant activity of azido-Warfarin
por: Ursuegui, Sylvain, et al.
Publicado: (2017)

State-of-the-Art Native Mass Spectrometry and Ion Mobility Methods to Monitor Homogeneous Site-Specific Antibody-Drug Conjugates Synthesis
por: Deslignière, Evolène, et al.
Publicado: (2021)

Siderophore conjugation with cleavable linkers boosts the potency of RNA polymerase inhibitors against multidrug-resistant E. coli
por: Peukert, Carsten, et al.
Publicado: (2023)

Homogeneous antibody-drug conjugates: DAR 2 anti-HER2 obtained by conjugation on isolated light chain followed by mAb assembly
por: Farràs, Mercè, et al.
Publicado: (2019)

Linker Length Matters, Fynomer-Fc Fusion with an Optimized Linker Displaying Picomolar IL-17A Inhibition Potency
por: Silacci, Michela, et al.
Publicado: (2014)

Antibody-drug conjugates: recent advances in conjugation and linker chemistries
por: Tsuchikama, Kyoji, et al.
Publicado: (2016)

Sulfatase-cleavable linkers for antibody-drug conjugates
por: Bargh, Jonathan D., et al.
Publicado: (2020)

Peroxide-cleavable linkers for antibody–drug conjugates
por: Ashman, Nicola, et al.
Publicado: (2023)

Improving Antibody‐Tubulysin Conjugates through Linker Chemistry and Site‐Specific Conjugation
por: Hamilton, Joseph Z., et al.
Publicado: (2021)

Perfluorophenyl Derivatives as Unsymmetrical Linkers for Solid Phase Conjugation
por: Alapour, Saba, et al.
Publicado: (2018)

Linkers: An Assurance for Controlled Delivery of Antibody-Drug Conjugate
por: Sheyi, Rotimi, et al.
Publicado: (2022)

Antibody–drug conjugates: Recent advances in linker chemistry
por: Su, Zheng, et al.
Publicado: (2021)

Lysosomal-Cleavable Peptide Linkers in Antibody–Drug Conjugates
por: Balamkundu, Seetharamsing, et al.
Publicado: (2023)

Linkers Having a Crucial Role in Antibody–Drug Conjugates
por: Lu, Jun, et al.
Publicado: (2016)

Linker Hydrophilicity Modulates the Anticancer Activity of RGD–Cryptophycin Conjugates
por: Anselmi, Michele, et al.
Publicado: (2020)

New Alkyne and Amine Linkers for Versatile Multiple Conjugation of Oligonucleotides
por: Honcharenko, Dmytro, et al.
Publicado: (2020)

Lengthening the Guanidine–Aryl Linker of Phenylpyrimidinylguanidines Increases Their Potency as Inhibitors of FOXO3-Induced Gene Transcription
por: Kohoutova, Klara, et al.
Publicado: (2022)

Cationic Oligospermine-Oligonucleotide Conjugates Provide Carrier-free Splice Switching in Monolayer Cells and Spheroids
por: Nothisen, Marc, et al.
Publicado: (2018)

Improving the Serum Stability of Site-Specific Antibody Conjugates with Sulfone Linkers
por: Patterson, James T., et al.
Publicado: (2014)

Acid-cleavable thiomaleamic acid linker for homogeneous antibody–drug conjugation
por: Castañeda, Lourdes, et al.
Publicado: (2013)

Radiation Cleaved Drug-Conjugate Linkers Enable Local Payload Release
por: Quintana, Jeremy M., et al.
Publicado: (2022)

Improved Dye Survival in Expansion Microscopy through Stabilizer‐Conjugated Linkers
por: Wen, Gang, et al.
Publicado: (2022)

Synthesis of multivalent polymer–aptamer conjugates with enhanced inhibitory potency
por: Martin, Jacob T, et al.
Publicado: (2018)

Fatty acid conjugation enhances potency of antisense oligonucleotides in muscle
por: Prakash, Thazha P, et al.
Publicado: (2019)

Multivalent peptidic linker enables identification of preferred sites of conjugation for a potent thialanstatin antibody drug conjugate
por: Puthenveetil, Sujiet, et al.
Publicado: (2017)

Convenient methods for preparing π-conjugated linkers as building blocks for modular chemistry
por: Kulhánek, Jiří, et al.
Publicado: (2009)

Effects of antibody, drug and linker on the preclinical and clinical toxicities of antibody-drug conjugates
por: Donaghy, Heather
Publicado: (2016)

Conjugation of Doxorubicin to siRNA Through Disulfide-based Self-immolative Linkers
por: Gauthier, Florian, et al.
Publicado: (2020)

Impact of linker-drug on ion exchange chromatography separation of antibody-drug conjugates
por: Zhang, Zhaorui, et al.
Publicado: (2019)

PEG Linker Improves Antitumor Efficacy and Safety of Affibody-Based Drug Conjugates
por: Li, Qiyu, et al.
Publicado: (2021)

Impact of Linker Modification and PEGylation of Vancomycin Conjugates on Structure-Activity Relationships and Pharmacokinetics
por: Umstätter, Florian, et al.
Publicado: (2022)

Expanding the Scope of the Cleavable N-(Methoxy)oxazolidine Linker for the Synthesis of Oligonucleotide Conjugates
por: Aho, Aapo, et al.
Publicado: (2021)

Correction: Use of pyridazinediones as extracellular cleavable linkers through reversible cysteine conjugation
por: Bahou, Calise, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_28b9n9omgjprshk4mdjas25781